Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
×

Get our best content in your email.

You are already a member! Please enter your password to sign in.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

Spectral Medical Inc T.EDT

Sector: Healthcare | Sub-Sector: Diagnostics & Research
Alternate Symbol(s):  EDTXF

Spectral Medical Inc is engaged in the development and commercialization of theranostic treatment for severe sepsis utilizing its Endotoxin Activity Assay diagnostic and the Toraymyxin therapeutic. It also manufactures and sells proprietary reagents.
Price: $0.83 | Change: $0.00 | %Change: 0.00%
Volume: 49,984 | Day High/Low: 0.83/0.82 | 52 Week High/Low: 1.18/0.265
View modes: 
0 stars

Meddwell's "consulting time" at Bioniche..now Tell-lesta

I starting to understand more and more about hoe to "consult" Telesta is a CARBON COPY of Spectral when it comes to the bullboards and the trading. I believe that BIONICHE is nearly as tightly held as...read more
0 stars

RE:If we achieve a 43% relative or 30% absolute rate as below

I'm not sure I follow. I thought you just wrote 14% absolute and 2% relative.  rate and reply
0 stars

If we achieve a 43% relative or 30% absolute rate as below

What are the predcitions for our share The Polymyxin column has been safely treating patients since 1994 in Japan and has been the subject of nearly 60 clinical papers. The most similar trial to our...read more
0 stars

RE:Analyst told us 3 months ago it's a composite rate of 55%

Does the relatively low absolute mortality benefit and slight improvement versus the first 184 patients suggest a stronger likelihood that the FDA will need a larger trial size before approval?  rate and reply
0 stars

RE:RE:RE:When you "own it ALL" and clearly they do........

Funny thing...I believe they use that "red dye" in the pool to quickly locate newcomers - LOL. No need for urination to trigger "red dye", just be an unwelcome visitor ; - )  rate and reply
0 stars

RE:RE:When you "own it ALL" and clearly they do........

If that were true it's easily rectified by management . possible tools: Clarifying news release phone call to analyst phone call to new analyst SWYG is right. The powers that be require...read more
0 stars

RE:When you "own it ALL" and clearly they do........

will say manufactured TIDE by our friendly analysts to scare the investors:)))))) glta go spectral  rate and reply
0 stars

When you "own it ALL" and clearly they do........

The "tide" is generated by flutter boards in a 16 X 32 in-ground pool ; - )  rate and reply
0 stars

RE:CEO Walker is why I'm here- see his prediction from 2012

SWGY Paul is well respected honest and with vast experience but sad but true market needs news atleast for small bios:))) hoping paul will help spectral to get the needed approval against the tide as...read more
2.5 stars

According to recent statistics ...

138,750 PEOPLE are being diagnosed with Sepsis in the US alone, each and every month ! With a mortality rate of up to 50 %. I wonder if the FDA takes that into consideration as they evaluate our...read more
3 stars

One Wonders...

...when the company might clear up confusion, and inconsistencies (evident on this board) regarding timelines (influenced by stats including composite mortality, MOD scores, patient counts needed, etc...read more
0 stars

CEO Walker is why I'm here- see his prediction from 2012

Medgadget may 2012.........................................................Dr. Paul Walker: The Polymyxin column has been safely treating patients since 1994 in Japan and has been the subject of...read more
3 stars

Analyst told us 3 months ago it's a composite rate of 55%

He didn't "make it up". I'm no medical sturgeon, but using the 62.5% rate, this would put our absolute benefit at 14%, only 2% higher than the first 184'ISH patients. We are dealing with very sick...read more
3 stars

RE:50 % and greater composite mortality rate ....

With MODS of 9 to 12, mortality is 50%. With MODS between 13 to 16, it is 75%. So we can take 62.5% average mortality rate. With 50% or greater composite mortality rate, it suggests a mortality rate...read more
4 stars

50 % and greater composite mortality rate ....

Is what the updated presentation indicates on the spectral medical company Web site  rate and reply
1.5 stars

Dirty little birdies everywhere..........

Surprising to see this from Diamond, especially since you got a the "2 thumb up treatment from Beech" That's almost like getting a Norris or a Selke......looks like you even fooled Beech...that's...read more
0 stars

RE:Vast majority of Investors .......

Agree but for spectral it does not look as if we have many traders as the volume is too low.  The current PPS will rise in multiples if there is early approval as the expectations are very low may be ...read more
4 stars

Vast majority of Investors .......

The vast majority of Investers do not invest into "companies" .... but instead they invest in volume and spreads in pps.  Your day traders and "shorters" are a necessary "evil" that keeps the markets...read more
0 stars

Endgame/Up Listings and complete Fools.

Where is Gamma Grouch? This is important to all shareholders here. Quoting him..."Anyone that thinks that Spectral should waste time and money on trying to get uplisted to an American exchange is a...read more
0 stars

EAP & Two Clean shots

Where is Gamma Grouch? Too late in the game to even bother with EAP ? "EAP is nice but it was not designed for a late stage phase 3 trial that is on the cusp of proving something amazing. That's not...read more